Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#2143 most reported symptom for this vaccine
CSF immunoglobulin increased has been reported 3 times in association with Hepatitis B (Engerix-B) vaccination in VAERS. This represents 0.0% of all 73,280 reports for this vaccine.
Among these reports, 1 mentioned death (33.33%) and 1 involved hospitalization (33.3%).
CSF immunoglobulin increased is the #2143 most frequently reported symptom for Hepatitis B (Engerix-B) out of 2382 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 3 reports of CSF immunoglobulin increased after Hepatitis B (Engerix-B) vaccination may seem alarming, but context is critical.
The 33.33% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.